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Abstract.  FG human  pancreatic  carcinoma  cells use 
integrin  otv/35 as their primary  vitronectin  receptor 
since they fail to express integrin  o~v/33. These cells 
are unable to form  focal contacts,  spread,  or migrate 
on vitronectin  but readily do so on collagen in a/31 
integrin-dependent  manner.  Transfection  of FG cells 
with a  eDNA encoding  the integrin  t53  subunit results 
in the  surface expression of a  functional  integrin  otv/33 
heterodimer  providing  these cells with novel adhesive 
and biological properties.  Specifically,  FG cells ex- 
pressing  133 acquire  the capacity to attach and  spread 
on vitronectin  as well as fibrinogen  with/33  localiza- 
tion to focal contacts.  Moreover,  these cells gain  the 
capacity to migrate  through  a  porous membrane  in re- 
sponse to either vitronectin  or fibrinogen.  These re- 
sults demonstrate  that the/33  and/35  integrin  subunits 
when associated  with oev, promote distinct  cellular  re- 
sponses to a  vitronectin  extracellular  environment. 
I 
NTEGRINS are a family of cell surface molecules mediat- 
ing  diverse biological events involving  cell-matrix  as 
well as cell-cell interactions.  The term integrin denotes 
a functional linkage between the extracellular matrix and the 
cells' interior,  thus providing cellular responsiveness to the 
extracellular  environment  (Tamkun et al.,  1986;  Buck and 
Horowitz, 1987). Integrin-llgand  specificity is conferred by 
the  subunit  composition  of the  integrin  heterodimer  (,v/3) 
complex (Hynes, 1987; Ruoslahti and Pierschbacher,  1987). 
In some cases, a given integrin heterodimer may recognize 
multiple ligands or multiple integrins  may recognize com- 
mon  ligands.  The  biological  function  underlying  this  in- 
trinsic multiplicity and redundancy in ligand-integrin  inter- 
action is not well understood. 
The av integrin subunit is unique in that it associates with 
more than two/3 subunits including/31 (Bodary and McLean, 
1990;  Vogel et al.,  1990),  t33  (Cheresh  and  Spiro,  1987; 
Cheresh  et  al.,  1989b),  /35  (Cheresh  et  al.,  1989a),  /56 
(Sheppard et al.,  1990), and/38 (Moyle et al.,  1991). While 
the c~v/31 and otv/35 heterodimers appear to be restricted in 
their ligand binding specificity, the wr  heterodimer inter- 
acts with multiple ligands in an Arg-Gly-Asp (RGD)-depen- 
dent  manner  (Cheresh,  1987;  Cheresh  and  Spiro,  1987; 
Charo et al.,  1987).  We recently reported that while both 
w,,/33 and otv/35 contribute to melanoma and carcinoma cell 
adhesion to vitronectin, only o~v/33  was found to cluster into 
focal contacts.  In contrast,  otv/35 failed to localize to focal 
contacts  but  rather  clustered  in  small  patches  distributed 
over much of the cell surface (Wayner et al.,  1991).  Focal 
contacts,  or adhesion plaques are structures which traverse 
the  plasma  membrane  linking  the  extracellular  substrate 
with components of the cytoskeleton (Burridge et al.,  1988; 
Otey and Burridge,  1990). The ability of a cell to form focal 
contacts correlates with its ability to assemble an organized 
cytoskeleton which, in turn,  is prerequisite for cell spread- 
hag  and migration  (Dejana  et al.,  1987).  Thus  o~v/33 and 
otv/35 exhibit different responses upon binding immobilized 
vitronectin and thereby have the potential to mediate distinct 
signals within the cell. 
To  investigate  the  biological  role  of these  integrins  we 
identified a cell line, FG human carcinoma (Cheresh et al., 
1989),  which  fails  to  express  o~v/33 and  thus  adheres  to 
vitronectin  in an c~v/35-dependent  manner.  These cells are 
unable to spread or migrate on this ligand. Upon transfection 
of FG cells with a eDNA encoding the human/33  integrin 
subunit we could express ,v/33 in a functional form resulting 
in  the  ability  of these  cells  to  spread  and  migrate  on  a 
vitronectin  or fibrinogen  matrix.  Thus our results demon- 
strate that two homologous integrins,  expressed on the same 
cell and recognizing the same ligand,  can promote distinct 
signals potentiating diverse biological activities in response 
to a given extracellular  matrix. 
Materials and Methods 
Cells and Cell Culture 
FG is a human pancreatic carcinoma cell line that fails to express mRNA 
for the ~3 intngrin subunit (Cheresh et al., 1989).  FG-A and FG-B are two 
stably U'ansfected sub-lines: FG-B, is transfected with a full length eDNA 
encoding human/~3 gene; FG-A is a subline, transfected with vector alone. 
M21 human melanoma cells wore a gift from Dr. Donald Morton (Depart- 
ment of  Surgery, University of  California, Los Angeles, CA). All cells wore 
grown in RPMI 1640 with 10% FBS, 50/~g/rni gentamycin, and tested free 
from mycoplesma during these studies. 
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Integrin specific mAbs LM609 (avB3; Cheresh and Spiro, t987),  LM142 
(a'v; Cheresh and Harper,  1987), P4C10 (/~1; Carter et al., 1990); LM534 
(B1; Wayner et al.,  1991), and  P3G2 (ave5; Wayner et al.,  199t) were 
affinity purified from ascites on protein A-Sepbarose (AffiGel protein A 
MAPS H Kit; Bio-Rad Laboratories,  Richmond,  CA). mAb AP3 was a 
generous gift from Dr. Peter Newman (Blood Center of Southwestern Wis- 
consin,  Milwaukee, WI). 
Adhesive Ligands 
Vitronectin was prepared as described by Yatohgo et al. (1988), Fibrinogen 
was purified according to the method of Felding-Habermann  et al. (1992). 
Collagen type I was purchased  from Collaborative  Research (New Bed- 
ford, MA). 
cDNA Transfection of  FG Cells 
Full length eDNA encoding the human 83 integrin subunit, kindly provided 
by Dr. Larry Fitzgerald (University of Utah, Salt Lake City, UT) was ligated 
into the expression vector peDNAineo (Invitrogen,  San Diego, CA) and 
transfected  into  FG  carcinoma  cells  using  the  lipofectin  protocol 
(Calbiochem-Behring Corp.,  La Jolla, CA). In brief, sub-confluent adher- 
ent cells were incubated with 2 ptg eDNA and 40 t~g lipofectin for 24 h, 
allowed to recover for 48 h before selection in neomycin for 2 wk at a con- 
centrafion of 500 ~g/ml.  Neomycin-resistant cells were expanded arid the 
celt surface expression of ~,vB3 analyzed by flow cytometry using the ~3 
complex-specific antibody, LM609. Immunoreactive  cells were enriched 
with four consecutive rounds of fluorescence-activated cell sorting, after 
which we observed stable surface expression of avB3 in ~40% of the trans. 
fected cell line. Positive (fiG-B) and negative (FG-A) transfectant popula- 
tions were recovered and maintained  in vitro. 
Cell Surface  Labeling  and Immunoprecipitation 
Cell surface proteins were i2SI-labeled  using lactoperoxidase as previously 
described  (Cheresh et al.,  1989). Radiotabeled cells were lysed in R1PA 
buffer (10 mM "Iris, pH 7.2,  150 mM NaCI, containing 1% Triton X-100, 
1% deoxycholate, 0.1% SDS with 1% aprotinin (No. A6279; Sigma Chemi- 
cal Co., St. Louis, MO) and 1 mM PMSF prior to immunoprecipitation 
with integrin-specific mAbs coupled to Sepharose (Pharmacia,  Uppsala, 
Sweden) as described (Cheresh et al., 1989). Immunoprecipitates were ana- 
lyzed by SDS-PAGE (Laemmli,  1970) under non-reducing conditions on 
7.5% polyacrylamide gels and radiolabeled species visualized with autora- 
diography as previously described  (Cheresh,  1987). 
Adhesion Assay 
Cell adhesion assays were performed  as previously described with modi- 
fications (Wayner et al.,  1991). In brief, sterile,  untreated,  bacteriolog- 
ical-grade  polystyrene  48-well  cluster  plates  (Costal', Cambridge,  MA) 
were coated at 4~  overnight with adhesive ligands (200/~t at 10/~g/rnl in 
PBS) and immediately before use blocked with 5% BSA in PBS, pH 7.4, 
Cells were harvested with trypsin/EDTA,  washed once, and suspended in 
HBSS supplemented with 1% BSA, 1 mM CaCl2, 1 mM MgCl2, and 0.5 
mM MnCl2 and then added to appropriate wells. Cells were permitted to 
adhere for various times at 37~C in 5 % COz in the presence or absence of 
purified mAbs specific for various integrins (50 ~g/ml) or the synthetic pep- 
tides (50 raM) GRGDSPK, and SPGDRGK. Norvadhercnt cells were re- 
moved with gentle washing and celt attachment enumerated  from dye up- 
take.  Adherent cells were fixed with 3% paraformaldehyde,  stained with 
0.1% crystal violet, air dried, and extracted in 10% acetic acid. Dye uptake 
was determined  spectmphotometrically  at 600 nm. 
Cell spreading was evaluated before staining in the above adhesion assay 
and enumerated  from random quadruplicate  fields containing at least 100 
cells. 
Indirect ImmunoJtuorescence 
Cells were allowed to attach and spread on vitronectin- or fibrinogen-coated 
glass coverslips and stained by indirect immunofluorescence as described 
(Wayner et al., 1991). In brief, cells were fixed with 3 % paraformaldehyde, 
permeabilized with 10 mM Tris, pH 7.4, 150 mM NaCI, 1 mM CaCI2 con- 
taining 0.1% Triton X-100 for 1 min. Permeabilized cells were stained with 
mAb AP3 or antisera to human vitmnectin (60 rain at room temperature), 
washed and  counter  stained  (60 rain at room temperature)  with either 
rhodamine-conjugated goat anti-mouse IgG, or fluorescein-conjugated goat 
anti-rabbit  IgG  (Tago, Buriingame,  CA).  Focal  adhesion  plaques  were 
visualized  by  the  exclusion  of  vitronectin-specific  antibody  from  the 
cell-substrate  contacts  as  previously  described  OVayner et al.,  1991). 
Fluorescence  was detected  with  a  Photomicroscope  (Carl Zciss,  Ober- 
kochen, Germany) fitted with epifluorescence. 
Cell Migration  Assay 
Cell migration  assays were performed  using  modified Boyden chambers 
with a 6.5-mm ditto, lO-~m thickness, porous (8.0/tin) polystyrene mem- 
brane separating the two chambers  (Transwell|  Costar).  Soluble ligands 
(20 #g/ml) were placed in lower, migration chambers in 600 #1 of serum- 
free RPMI 1640 supplemented  with  1% ITS+  (Collaborative  Research, 
New  Bedford,  MA),  50  #g/ml gentamycin,  2.5  t~g/mi amphotericin  B 
(Sigma Chemical Co.), and then incubated at 37~  for 30 rain before the 
addition of cells. Sub-confluem 24-h cultures were harvested with trypsin/ 
EDTA, washed once, and resuspended in the serum-free RPMI without ad- 
hesive ligends. Cells (50,000) were added in 100 v.t to the upper chamber 
in the presence or absence of the synthetic peptides (50 raM) GRGDSPK, 
SPGDRGK, or mAbs (50 ~tg/ml) to various integrins. Migration is mea- 
sured after 48-h incubation at 37"C by counting the number of cells recov- 
ered from the floor of the lower chamber. Non-adherent cellular debris is 
removed with gentle washing and cells fixed with 3 % paraformaldehyde. 
Cell rni~ration was quantitated from photographs taken under phase con- 
trast of  quadruplicate, random fields from duplicate samples. Random (non- 
specific) migration was determined using the control protein BSA (20 t~g/ 
mi). Specific cell migration toward each matrix protein was calculated by 
subtracting BSA-mediated migration from total cell migration. In each case 
random migration 67% of total matrix-dependent migration. 
Results 
FG human carcinoma cells fail to express mRNA encoding 
the  integrin 83  subunit  (Cheresh  et  al.,  1989).  Thus we 
sought to determine the mechanism of FG cell attachment 
to vitronectin. FG cells were allowed to attach to vitronectin- 
or collagen-coated wells in the presence or absence of mAbs 
specific for integrins olv/~3, av/35, and El. As shown in Table 
I, FG cell attachment  to vitronectin can be significantly in- 
hibited (67%) with mAb P3G2 directed to integrin c~v/~5, 
while mAb LM609,  directed to ~,vB3, or mAb P4C10,  di- 
rected to the BI subunit,  have little or no effect. These data 
indicate that cev~5  is the primary vitronecfin receptor ex- 
pressed by FG cells. In contrast, mAbs LM609  and P3G2 
have little or no effect on FG cell  adhesion to collagen, 
whereas mAb P4C10 abolishes (91%) cell attachment on this 
substrate. 
M21  human melanoma cells express otv/~3 as their pri- 
mary vitronectin receptor (Wayner et al., 1991).  Therefore, 
as  shown in Table  I,  mAb  LM609  significantly  inhibited 
M21  cell adhesion to this matrix by 60%,  whereas mAb 
P3G2, specific for av~5, had a reduced effect (28%). The 
Bl-specific mAb, P4CIO, had minimal effect on M~21 cell at- 
tachment to vitronectin but completely inhibited attachment 
to collagen (97%), consistent with previous results (Strauss 
et al., 1989). These results collectively demonstrate that FG 
carcinoma cell adhesion to vitronecfin is primarily mediated 
by ~xv~5 while M21 melanoma cell attachment to this ligand 
primarily involves o~v/~3. 
To investigate  the biological consequences  of o~v/~3- or 
o~v/~5-dependent cell adhesion, we examined the capacity of 
FG cells or M21 cells to spread on vitronectin. As shown in 
Fig.  1, FG cells readily attach to, but do not spread on this 
matrix, even after 90 rain.  In contrast, these cells readily 
spread on a collagen matrix indicating that the intrinsic abil- 
ity Of FG cells to spread is not deficient. M21  human mela- 
noma cells, which use primarily o~vB3 to attach to vitronec- 
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to Vitronectin or Collagen* 
FG cells  M21  cells 
n'tAb  Vitronectin  Collagen  Vitronectin  Collagen 
P3G2  67*  2  28  14 
(~vfl5) 
LM609  0  4  60  5 
(c~v~3) 
P4CIO  22  91  19  97 
(ill) 
* FG  or M21  cells  were  allowed  to attach  to  vitronectin-  or collagen  (10 
#g/ml)-coated wells in the presence or absence of mAbs (50 #g/ml) for 60 min 
at 370C as described in Materials and Methods. Standard deviations were rou- 
tinely < 10%. 
* Represents percent inhibition of cell adhesion relative to adhesion in the ab- 
sence of antibody. 
View, CA); FG-B which expresses 133, and FG-A which fails 
to express 03.  As shown in Fig.  2,  immunoprecipitation 
analysis of ~2q-surface-labeled  FG transfectants reveals that 
both cell types express equivalent levels  of avB5 and 
integrins, mAb LM609, directed to the wr  complex, im- 
munoprecipitates this receptor from the 133 expressing FG-B 
sub-line and not from the FG-A (mock transfected) sub-line. 
mAb LM142, directed to the we subunit, immunoprecipi- 
tates this subunit associated with multiple/3 subunits, includ- 
ing 05 and 06 (Busk et al., 1992). These results demonstrate 
that transfection of FG cells with a cDNA encoding the 03 
integrin subunit results in the stable expression of  cry/33 com- 
plexes at the cell surface. Moreover these immunoprecipita- 
tion profiles  indicate that de novo expression of/3 3 in the 
FG-B population does not alter the expression of  other otv-in- 
tegrins, or Bl-integdns, which remain at equivalent levels in 
both cell populations. 
tin, rapidly spread on this matrix (Fig. 1). These data suggest 
that the homologous integrins otv03 and av05 mediate differ- 
ential biological functions in response to a common ligand. 
Transfection of  FG Cells with 03 cDNA Results in the 
Expression of  lntegrin avfl3 
To determine whether the inability of FG cells to spread on 
vitronectin is a  result of the specific absence  of integrin 
av/33, FG cells were transfeeted with an expression vector 
containing eDNA encoding the human/33 integrin subunit 
and a gene for neomycin resistance. After drug selection, 
two stable transfectant FG sub-lines were established from 
populations sorted for av/33 expression using FACS (a regis- 
tered  trademark  of Becton  Dickinson  &  Co.,  Mountain 
Expression of/33 in FG Cells Alters Their Biological 
Response to Vitronectin and Fibrinogen 
To establish whether FG-B cells express the o~v03 integrin 
in a functional form, cell adhesion assays were performed. 
FG-A and FG-B cells attach to vitronectin yet only FG-B 
cells can be inhibited with mAb LM609, directed to wr 
(55 %, not shown). This adhesion event results in FG-B cell 
spreading on both vitronectin (Fig. 3, A-C) and fibrinogen 
(Fig. 3 B,/eft) within 60 min. In contrast, the/33 negative, 
parental FG cells (Fig. 1) or mock-transfected FG-A cells not 
only fail to spread on vitronectin but are unable to attach to 
fibrinogen (not shown). Moreover, FG-B cells which spread 
on both of these substrata, express 03 in focal contacts (Fig. 
3, B and C) indicating that c~v/33 expression promotes the 
assembly of  adhesion plaques and organization of  the micro- 
Figure L  FG and  M21  cell 
spreading on vitronectin and 
collagen. FG human carcino- 
ma and M21 human melano- 
ma  cells  were allowed  to 
attach to vitronectin- or coUa- 
gen-coated (10#g/ml) polysty- 
rene wells at 37~  Nonadher- 
ent cells were removed with 
three  gentle washes as  de- 
scribed under  Materials and 
Methods. Attached cells were 
photographed at 200x under 
phase  contrast  using  Kodak 
TMXI00  (Eastman  Kodak 
Co.,  Rochester, NY), Bar, 
100 #m. 
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labeled  FG-A  (mock-transfected)  and  FG-B 
033-transfected)  cells.  FG  carcinoma  cells 
were transfected  with  a cDNA encoding  full- 
length human  83  and neomycin-resistance 
genes.  After  drug  selection  for  2  wk,  cells  were 
sorted  for  ave3  expression  by  FACs  and  stable 
sub-lines  established.  Cells  were nsI-surface 
labeled  and extracted  with  detergent  as de- 
scribed  in  Materials  and Methods. Detergent 
extracts  were immunoprecipitated  with  integ- 
rin-specific  mAbs coupled  to  Sepharose  beads. 
mAbs LM142 (av,  lane  A), LM609  (av#53, 
lane  B), P3G2 (av85,  lane  C), and LM534 
(~1, lane D). 
filament cytoskeleton leading to cell spreading on a vitronec- 
tin or fibrinogen matrix.  Approximately 40%  of the FG-B 
cell population express/~3 and only these cells were found 
to  spread on  vitronectin  or  fibrinogen.  In  addition,  mAb 
LM609 prevents cell spreading on vitronectin or fibrinogen 
providing further evidence for a role for o~v/33  in this process 
(data not shown). 
To further investigate the biological role of integrin av/~3 
we examined the capacity of this receptor to potentiate FG-B 
cell migration. For these experiments we used modified Boy- 
den chambers containing an 8.0 ~,m porous membrane.  FG 
cells do not demonstrate  significant  or specific migration 
through the 8.0 ~m pores separating these chambers in the 
presence of  the control ligand BSA. However, both FG-A and 
FG-B cells readily migrate toward a collagen source yet only 
FG-B cells, expressing av/33, are capable of migrating  to- 
ward vitronectin or fibrinogen (Fig. 4). FG-B cell migration 
to both vitronectin and fibrinogen is completely inhibited by 
mAb LM609 demonstrating that av/33 is responsible for this 
event (Fig. 4). In contrast, mAb P3G2, directed to ave5, had 
no effect on FG-A or FG-B cell migration  to all  substrata 
tested  (data  not  shown),  indicating  this  receptor  fails  to 
potentiate  migration  of these  cells.  In  addition  an  RGD- 
containing  synthetic  peptide  which  functionally  inhibits 
czv/33-mediated cell attachment (Cheresh et al., 1989), com- 
pletely blocks av/~3-dependent migration (data not shown). 
It is of interest that the migration of av/~3-expressing FG-B 
cells toward collagen is not significantly inhibited by mAb 
P4C10,  directed  to  /31  integrins,  suggesting  an  additional 
mechanism in these cells (Fig. 4). In fact, integrin av/~3 has 
been reported, in some cells, to recognize collagen (Kramer 
et al.,  1990) suggesting that, in addition to vitronectin and 
fibrinogen,  av/33,  when  present,  may  also  contribute  to 
collagen-dependant  cell migration. 
Discussion 
This  study  was  designed  to  characterize  the  biological  prop- 
erties  of  two structurally  and functionally  related  integrins 
avfl3 and avfl5 which are  often  expressed  on  the  same cell 
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cell attachment and spreading on vitronec- 
tin and fibrinogen with ~3 localization to 
focal contacts.  /~3-Transfected FG-B cells 
were allowed to attach and spread on vitro- 
nectin-coated coverslips for 60 rain. Non- 
adherent cells  were removed with  gentle 
washing and  attached  ceils  evaluated for 
spreading with phase-contrast microscopy 
(,4). For fluorescence experiments  FG-B 
cells  were  allowed to  attach  and  spread 
on vitronectin- or fibrinogen-coated cover- 
slips, fixed, permeabilized, and stained with 
mAb AP3 directed to the/53  integrin sub- 
unit, or anti-sera to vitronectin (B and C, 
respectively)./53 staining in cells spread on 
fibrinogen (B,/eft) and vitronectin (B, cen- 
ter and right) exactly co-distributes with fo- 
cal contacts, visualized by the exclusion of 
vitronectin-specific antibody from the cell- 
substrate contacts as described under Mate- 
rials and Methods (C, ~3, left; anti-vitronec- 
tin,  right;  arrows,  co-localized staining). 
Representative  cells  were  photographed 
with  a  Zeiss  microscope fitted with epi- 
fluorescence. Bars: (A) 25 tam; (8 and C) 
10 tam. 
(Wayner et al., 1991). These receptors bind vitronectin in an 
RGD-dependent manner,  contain  identical a  subunits and 
structurally  similar fl  subunits  (Cheresh and  Spiro,  1987; 
Cheresh et al., 1989; McLean et al., 1990; Ramaswamy and 
Hemler, 1990; Suzuki et al.,  1990). However, the cytoplas- 
mic tails of/33 and t5 are structurally distinct thus raising 
the possibility that avfl3 and c~vfl5 mediate differential bio- 
logical signals  in response to vitronectin. 
In this  report we provide several  lines of evidence that 
these  integrins  mediate distinct biological  responses  to  a 
vitronectin substrate.  Firstly, FG carcinoma cells use avfl5 
as their major vitronectin receptor since they fail to express 
/33 mRNA or protein (Cheresh et al.,  1989) and attach but 
fail to spread on vitronectin and are incapable of attaching 
to fibrinogen. This is not because of a general deficiency in 
FG cell spreading since these cells readily attach and spread 
on collagen in an integrin El-dependent manner. Secondly, 
M21  cells,  which express a,  vfl3 as their major vitronectin 
receptor (Wayner et al.,  1991),  attach and spread on both 
vitronectin and fibrinogen with ocv~3 expressed in focal con- 
tacts at  the end of actin  filament bundles  (Wayner et al., 
1991). Thirdly, transfection of/33 negative FG cells with a 
cDNA encoding t3 results in the surface expression of avfl3 
which  enables  these  cells  to  spread  on  vitronectin  and 
fibrinogen. Moreover,/33 localizes to focal contacts on these 
transfected FG cells indicating that otvfl3 is directly involved 
in cell  spreading on these matrix proteins.  Finally,  FG-B 
cells expressing the 83 gene product not only spread, but ac- 
quire the ability to migrate in response to vitronectin and 
fibrinogen. That this is because of the presence of uv~3 on 
these cells is demonstrated by the ability of mAb LM609 
(anti-otvfl3)  or  an  RGD-containing  peptide  to  block  this 
migration. These results provide a rationale for the expres- 
sion of uvfl3 and avfl5 on the same cell where oecfl5 pro- 
motes simple adhesion while av~3 enables cells to modify 
their shape and mobility on vitronectin. 
Although o~vfl5 is the major vitronectin-binding integrin 
on FG cells we cannot completely exclude the possibility that 
additional  vitronectin-binding  integrins  are  expressed  on 
these cells other than a,  vfl3. For example, integrin av~l ap- 
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tion. Vitronectin, collagen, and fibrinogen (20 t~g/ml)  in serum-free 
medium were placed into the lower chamber of a modified Boyden 
chamber separated by an 8.0 ttm porous membrane from FG-A (n) 
or FG-B (I) cells placed into the upper chamber in the absence 
(Control) or presence of mAbs LM609 (anti-c~v/~3)  or P4C10 (anti- 
/~1). Migratory cells which had traversed the membrane into the 
lower chamber were counted (mean of four random fields +  SE) 
after 45-h  incubation at 37"C.  Random, non-specific migration 
(when BSA is placed into the lower chamber) has been subtracted, 
was ~7% of the total migration in response to any substrate. 
parently mediates vitronectin adhesion of certain ceils (Bo- 
dary and McLean, 1990). It is conceivable that c,v/31 could 
play a  minor role in FG cell and M21  cell attachment to 
vitronectin since mAb  P4C10  directed to/31  partially in- 
hibited  the  attachment  of both  cell  types  to  vitronectin 
(,,020%).  However, immunoprecipitation analysis failed to 
detect otv/31 on either cell type. In any event the expression 
of c~v/31 or another vitronectin-binding integrin on FG cells 
does  not  account  for  measurable  cell  spreading  and/or 
migration on vitronectin. 
The cytoplasmic tail of the/35 subunit is structurally dis- 
tinct from those of the/31  and/33 subunits (Ramaswamy and 
Hemler, 1990; McLean et al., 1990; Suzuki et al., 1990) and 
thus may be responsible for a  distinct signal transduction 
event. Alternatively, it is conceivable  that this subunit is sim- 
ply incapable of interacting with one or more cytoplasmic 
proteins thought to be involved in the assembly of focal con- 
tacts. For example, talin and o~-actinin, two proteins found 
in focal contacts, have been shown to directly bind integrins 
(Horowitz et al.,  1986). In fact, o~-actinin directly binds to 
a peptide derived from the cytoplasmic tail of/31 (Otey et al., 
1990). Based on a mutational analysis of the/51 integrin it 
appears that the structural basis of integfin focal contact for- 
marion depends on three domains with the cytoplasmic tail 
of/31 (Reszka and Horowitz, 1992). It is noteworthy that/31 
and/33 are extremely well conserved in each of these regions 
while/35 has virtually no sequence homology in the most 
COOH-terminal  of these  domains.  It  is  conceivable that 
specific residues within this particular domain fail to support 
the localization of o~v/35 into focal contacts. To test this hy- 
pothesis it will be necessary to examine the expression of 
truncated and/or chimeric integrin heterodimers in cells that 
normally fail to form focal contacts on a  vitronectin sub- 
strate. It is also interesting to note that the cytoplasmic tail 
of/35 contains five serine residues not found in/31  or/33 
(Ramaswamy  and  Hemler,  1990;  McLean  et  al.,  1990; 
Suzuki  et al.,  1990).  Perhaps phosphorylation of one or 
more of these prevents the localization of t~v/35 to focal con- 
tacts. In fact, the/3s subunit which may be related or identi- 
cal to/35 becomes phosphorylated on serine in response to 
activators of protein kinase C  (Freed et al.,  1989). 
The differential ability of cry/33 and oev/35  to promote cell 
spreading and migration may have profound biological im- 
plications during events associated with development, wound 
healing, and neoplasia where cell migration is known to take 
place. Thus, the genetic regulation of/33 and/35 may play 
a key role in determining the migratory status of a cell. Re- 
cent evidence supports this hypothesis. Non-differentiated 
keratinocytes, which are known to be migratory, express 
both av/33 and o~v/35  integrins while terminally differentiated 
keratinocytes, which do not migrate, no longer express 0o~/33 
(Adams and Watt,  1991).  Furthermore, the/33 subunit ex- 
pressed  by  sub-confluent  embryonic  lung  fibroblasts,  is 
down regulated when these cells reach confluence (Bates et 
al., 1991). The role of  o~v/33 in melanoma cell migration may 
be very relevant for the metastatic phenotype of these cells. 
In fact, 0~v/33 was found to be preferentially expressed on 
metastatic and vertically invasive primary lesions whereas it 
was not detected on normal melanocytes, nevi, or horizontal 
primary melanoma (Albelda et al., 1990). The promiscuous 
ligand-binding capacity of oLv/33 suggests that ceils express- 
ing this receptor can migrate on a wide variety of matrices 
and  basement  membranes.  Our  results  demonstrate  that 
fibrinogen a  known ligand for c~v/33 (Cheresh,  1987) can 
promote the migration of/3 3 transfected FG cells. Therefore 
the expression of r  and the resulting phenotype may play 
an important role in a wide range of migratory events involv- 
ing multiple biological phenomena. 
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